Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Raben

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
BJU International|February 18, 2009
Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent mannerThomas W Flaig, Lih-Jen Su, Caroline McCoach, et al.
Journal of the American Academy of Dermatology|December 17, 2015
Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United StatesArya Amini, Chad G Rusthoven, Timothy V Waxweiler, et al.
Head & Neck|December 9, 2014
Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter reviewTyler P Robin, Gregory N Gan, Moses Tam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2011
Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancerNeha P Amin, Moyed Miften, Brian Kavanagh, et al.
The Journal of Urology|November 19, 2015
Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data BaseArya Amini, Bernard Jones, Matthew W Jackson, et al.
Urologic Oncology|March 18, 2014
The prognostic significance of Gleason scores in metastatic prostate cancerChad G Rusthoven, Julie A Carlson, Timothy V Waxweiler, et al.
Oncology (Williston Park, N.Y.)|July 18, 2006
Metastatic malignant melanoma from an unknown primary presenting as a large axillary massKarl D Lewis, Susan Dollarhide, James E Fitzpatrick, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer SymposiumPaul M Harari, Roger B Cohen, David Raben, et al.
Oral Oncology|August 12, 2017
Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United StatesWilliam A Stokes, Priscilla K Stumpf, Bernard L Jones, et al.
American Journal of Clinical Oncology|June 6, 2008
Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trialAri Ballonoff, Brian Kavanagh, Martin McCarter, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
BJU International|February 18, 2009
Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent mannerThomas W Flaig, Lih-Jen Su, Caroline McCoach, et al.
Journal of the American Academy of Dermatology|December 17, 2015
Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United StatesArya Amini, Chad G Rusthoven, Timothy V Waxweiler, et al.
Head & Neck|December 9, 2014
Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter reviewTyler P Robin, Gregory N Gan, Moses Tam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2011
Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancerNeha P Amin, Moyed Miften, Brian Kavanagh, et al.
The Journal of Urology|November 19, 2015
Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data BaseArya Amini, Bernard Jones, Matthew W Jackson, et al.
Urologic Oncology|March 18, 2014
The prognostic significance of Gleason scores in metastatic prostate cancerChad G Rusthoven, Julie A Carlson, Timothy V Waxweiler, et al.
Oncology (Williston Park, N.Y.)|July 18, 2006
Metastatic malignant melanoma from an unknown primary presenting as a large axillary massKarl D Lewis, Susan Dollarhide, James E Fitzpatrick, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer SymposiumPaul M Harari, Roger B Cohen, David Raben, et al.
Oral Oncology|August 12, 2017
Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United StatesWilliam A Stokes, Priscilla K Stumpf, Bernard L Jones, et al.
American Journal of Clinical Oncology|June 6, 2008
Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trialAri Ballonoff, Brian Kavanagh, Martin McCarter, et al.
Pageof 17